Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. 1987

T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892.

The epidermal growth factor (EGF) receptor gene EGFR has been placed in a retrovirus vector to examine the growth properties of cells that experimentally overproduce a full-length EGF receptor. NIH 3T3 cells transfected with the viral DNA or infected with the corresponding rescued retrovirus developed a fully transformed phenotype in vitro that required both functional EGFR expression and the presence of EGF in the growth medium. Cells expressing 4 x 10(5) EGF receptors formed tumors in nude mice, while control cells did not. Therefore, the EGFR retrovirus, which had a titer on NIH 3T3 cells that was greater than 10(7) focus-forming units per milliliter, can efficiently transfer and express this gene, and increased numbers of EGF receptors can contribute to the transformed phenotype.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast

Related Publications

T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
October 1999, Japanese journal of cancer research : Gann,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
September 1995, The Journal of biological chemistry,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
January 1989, Contributions to gynecology and obstetrics,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
April 1989, The Journal of biological chemistry,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
May 2001, The Journal of biological chemistry,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
December 1994, Proceedings of the National Academy of Sciences of the United States of America,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
January 1988, Biochemical and biophysical research communications,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
April 1986, The Journal of biological chemistry,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
June 1990, The Journal of biological chemistry,
T J Velu, and L Beguinot, and W C Vass, and M C Willingham, and G T Merlino, and I Pastan, and D R Lowy
June 2004, Biochemical Society transactions,
Copied contents to your clipboard!